Effect of Deksmedetomidine and Remifentanil in Extubation Agitation | NCT02104297 | Trialant

Unknown statusInterventionalPhase 4Updated Apr 4, 2014

Effect of Deksmedetomidine and Remifentanil in Extubation Agitation

The Effect of Deksmedetomidin and Remifentanil Infusion on Extubation Agitation and Recovery Conditions on Nasal Septoplasty Operation

Overview

Key facts that identify this study and show where it stands today.

ClinicalTrials.gov ID: NCT02104297
Lead Sponsor: Diskapi Yildirim Beyazit Education and Research HospitalOTHER_GOV
Overall Status: Unknown status
Study Type: Interventional
Phase: Phase 4
Enrollment: 90Estimated
Last Update Posted: Apr 4, 2014Estimated
Start Date: Apr 2014
Primary Completion Date: Jun 2014Estimated
Completion Date: Jun 2014Estimated

What the study is about and why it is being run, in the researchers' own words.

Official Title: The Effect of Deksmedetomidin and Remifentanil Infusion on Extubation Agitation and Recovery Conditions on Nasal Septoplasty Operation
Brief Summary: To compare the effect of two different agents deksmedetomidine, remifentanil and placebo, agitation and recovery condition, on nasal septum operation.
Detailed Description: Nasal septum operation cause agitation because of nasal package. This research aims determine which agent , deksmedetomidine remifentanil or placebo, is more beneficial to the patient.

The medical conditions and diseases this study investigates.

The treatments and procedures being evaluated in this study.

Who can join this study and the criteria used to decide.

Ages Eligible for Study: Adult (18-64)Older Adult (65+)
Sexes Eligible for Study: All
Accepts Healthy Volunteers: Yes
Eligibility Criteria: Inclusion Criteria:

Adult patients

Exclusion Criteria:

patients with any sensitivity each drug

How the study is designed and how its participant groups are organized.

The people to reach with questions about this study or how to join it.

Reyhan Polat, MDContact

reyhanp9@gmail.com+905326734310

Where the study is run and whether each site is currently recruiting.

Reyhan Polat

Ankara, 06610, Turkey (Türkiye)

The organizations and people involved in this study.

Lead Sponsor: Diskapi Yildirim Beyazit Education and Research HospitalOTHER_GOV

Other registered studies that closely resemble this one.